Premium
Middle segment pancreatectomy for the treatment of benign and low malignant potential pancreatic tumours
Author(s) -
Lou WenHui,
Jin DaYong,
Niu WeiXin,
Ni XiaoLin,
Wu WenChaun
Publication year - 2006
Publication title -
surgical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.109
H-Index - 10
eISSN - 1744-1633
pISSN - 1744-1625
DOI - 10.1111/j.1744-1633.2006.00292.x
Subject(s) - medicine , pancreas , pancreatectomy , mucinous cystadenoma , distal pancreatectomy , splenectomy , pancreatic cancer , surgery , spleen , cancer
Background: Conventional distal pancreatectomy is used for the removal of lesions located at the body and tail of the pancreas. Generally, the spleen is sacrificed. But for benign and low malignant potential tumours in the pancreatic neck and body, this incurs notable loss of normal pancreatic tissue and the unnecessary risk of diabetes mellitus as well as splenic loss. Methods: We report three cases of middle segment pancreatectomy in an effort to avoid the unnecessary loss of normal pancreatic tissue and the spleen. Two patients were males with a mucinous cystadenoma and non‐cystic mucinous cystadenocarcinoma. The other was a female with a serous cystadenoma. Middle segment pancreatectomy was performed. Two patients were reconstructed with double pancreaticojejunostomy and the third with a pancreaticogastrostomy. Results: No major complications were observed. Comnclusions: Middle segment pancreatectomy is a safe and effective procedure for the resection of benign and low malignant potential tumours in the pancreatic neck and body with preservation of normal pancreatic tissue and the spleen in selected patients. This is the first report of middle segment pancreatectomy for pancreatic tumour in China.